CTI BioPharma

1 follower


CTI BioPharma (NASDAQ: CTIC) is a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies for blood-related cancers that offer a unique benefit to patients and their healthcare providers.

Employees

201-500

Links


Org chart

Adam R. Craig
President, CEO & Interim Chief Medical Officer
Collapse
James K. Fong
SVP, Commercial Operations
William Born
Senior Director Strategic Pricing And Contracting
Mary Beth Lanza
Senior Director Learning And Development
Shah Nawaz Sulehria
Operations Manager Development Program
Wendy Wilson
Associate Director Medical Affairs
Allison Hylton
Senior Corporate Controller/senior Director
Dawn Waldorf
Key Account Manager

Board & advisors